Clinical Trials in Tennessee

Showing 5721-5740 of 15,329 trials

RF Ablation of the Trigone for the Treatment of UUI

NCT04408352

The primary objective of this pivotal study is to collect data on the safety and effectiveness of the Hologic trigone RF ablation device to reduce urgency urinary incontinence. Up to 325 subjects will be enrolled with 225 randomized (2:1) and treated at up to 35 sites in the U.S. Additional sites in Canada, Australia, Europe, and other countries may also be considered. Sites outside of the U.S. cannot randomize more than 25% of subjects.

Urgent Urinary Incontinence

Hologic, Inc.225 participantsStarted Apr 2020

Wichita, Kansas, United States • Shreveport, Louisiana, United States • Pittsburgh, Pennsylvania, United States +3 more locations

COMPLETEDPhase 229 miles

Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19

NCT04372628

Blinded, multicenter, placebo-controlled, randomized clinical trial evaluating lopinavir/ritonavir vs placebo in early outpatient treatment of adults with COVID-19

COVID-19

Vanderbilt University Medical Center452 participantsStarted Jun 2020

Aurora, Colorado, United States • Boston, Massachusetts, United States • Jackson, Mississippi, United States +3 more locations

COMPLETEDNA29 miles

Cardionomic STOP-ADHF Study

NCT04814134

STOP-ADHF Study: An evaluation of the safety and performance of the Cardionomic Cardiac Pulmonary Nerve Stimulation (CPNS) system in patients with acute decompensated heart failure.

Acute Decompensated Heart Failure

Cardionomic Inc.59 participantsStarted Apr 2021

Indianapolis, Indiana, United States • Akron, Ohio, United States • Cincinnati, Ohio, United States +12 more locations

RF Ablation of the Trigone for the Treatment of UUI

Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19

Cardionomic STOP-ADHF Study

Find Trials by Condition in Tennessee

A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis

Gene Therapy With hLB-001 in Pediatric Patients With Severe Methylmalonic Acidemia

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer

Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer

Electrically Evoked Compound Action Potentials Human Observation Medtronic Algorithm Comparison Study

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

OCS Lung System EXPAND II Trial

Pilot Prospective Study: Long-term Health of Living Kidney Donors

Evaluation of the Safety and Clinical Performance of the Connected Catheter Study

A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)